Kumar Ashish
Department of Gastroenterology and Hepatology, Sir Ganga Ram Hospital, New Delhi 110 060, India.
Indian J Gastroenterol. 2012 Apr;31(2):43-54. doi: 10.1007/s12664-012-0174-4. Epub 2012 Apr 21.
Hepatitis B virus (HBV) infection is a global problem and the world has 350 million carriers of chronic hepatitis B. Over 50 % of these have acquired their infection vertically from their mothers (mother-to-child transmission [MTCT]). Majority (>90 %) of vertically-acquired infection results into chronic infection, due to induction of an immune-tolerant state. Hence, management of chronic HBV during pregnancy and strategies to prevent MTCT would go a long way in global control of HBV infection and the morbidity and mortality associated with it. However, chronic HBV infection in pregnancy presents a unique challenge, because of existence of a complex relationship between the physiological changes of pregnancy and the pathophysiological response of body to HBV. This relationship may lead to a varied presentation of the patient to the doctor depending on the period of her pregnancy and stage of her liver disease. Each of these modes of presentation raises issues that need to be addressed for successful maternal and fetal outcome, including prevention of MTCT of HBV. This review will try to give a practical approach in addressing these issues.
乙型肝炎病毒(HBV)感染是一个全球性问题,全球有3.5亿慢性乙型肝炎携带者。其中超过50%是通过母婴垂直传播(母婴传播[MTCT])感染的。由于诱导了免疫耐受状态,大多数(>90%)垂直感染会导致慢性感染。因此,孕期慢性HBV的管理以及预防母婴传播的策略对于全球控制HBV感染及其相关的发病率和死亡率将大有帮助。然而,孕期慢性HBV感染带来了独特的挑战,因为孕期的生理变化与身体对HBV的病理生理反应之间存在复杂的关系。这种关系可能导致患者根据其孕期和肝病阶段向医生呈现不同的症状。这些呈现方式中的每一种都提出了为实现母婴成功结局(包括预防HBV母婴传播)而需要解决的问题。本综述将尝试给出解决这些问题的实用方法。